February 20, 2018 8:46 PM ET


Company Overview of ObeTherapy Biotechnology SAS

Key Executives for ObeTherapy Biotechnology SAS

NameBoard RelationshipsTitleAge
Itzik Harosh 10 RelationshipsFounder, Chairman of the Board, CEO & Chief Scientific Officer--
Marco A. Ciufolini No RelationshipsAdvisor--

ObeTherapy Biotechnology SAS Board Members*

NameBoard RelationshipsPrimary CompanyAge
Itzik Harosh 10 RelationshipsObeTherapy Biotechnology SAS--
Miroslav Radman Ph.D. 30 RelationshipsDeinove SA--
David Bensimon Ph.D. 10 RelationshipsObeTherapy Biotechnology SAS--
Avraham Levy Ph.D. 20 RelationshipsEvogene Ltd.--
Timor Baasov Ph.D. 10 RelationshipsObeTherapy Biotechnology SAS--
View All Board Members

ObeTherapy Biotechnology SAS Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
ObeTherapy Biotechnology SAS CEO Compensation
Industry Average


ADMA Biologics, Inc. Announces Executive Resignations
February 16, 2018 10:21 PM ET
Keryx Biopharmaceuticals, Inc. Announces Resignation of Brian Adams as General Counsel and Secretary
February 16, 2018 9:31 PM ET
Ablynx NV Announces Executive Changes
February 16, 2018 9:06 PM ET
Editas Medicine, Inc. Appoints Jessica Hopfield to its Board of Directors
February 16, 2018 2:00 PM ET
Arena Pharmaceuticals, Inc. Announces Changes to Board of Directors
February 16, 2018 1:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ObeTherapy Biotechnology SAS, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.